Spanish Lung Cancer Group Publishes Updated Summary of Mesothelioma Patient Outcomes

When it comes to cancer treatment and outcomes, every day seems to bring new innovations and improvements. But according to a recently published study from a respected research cooperative of Spanish oncologists, patients diagnosed with malignant pleural mesothelioma continue to face steep challenges and grim overall survival times.

New Early Lung Cancer Test May Help Diagnose Malignant Pleural Mesothelioma

When researchers at the 2019 World Conference on Lung Cancer announced they’d seen positive results from a new early lung cancer detection tool, it raised the hopes of mesothelioma physicians around the world. The rare and fatal form of lung cancer caused by exposure to asbestos is notoriously difficult to treat, and one of the

Conrail Loses Asbestos-Related Lung Cancer Case Against Ex-Smoker

The scientific community has determined that exposure to asbestos dramatically increases the risk that cigarette smokers will be diagnosed with malignant mesothelioma, and the same is true of lung cancer. Yet despite incontrovertible evidence in support of this connection, Consolidated Rail Corporation (Conrail) argued in court against its responsibility for a longtime railroad worker’s diagnosis

Couple Wins Right to Sue Ford Motor Company Over Asbestos Lung Cancer

When people are first diagnosed with malignant mesothelioma or other asbestos-related diseases, they’re often shocked to learn that they were exposed to asbestos by iconic companies like Ford Motor Company. That is exactly what happened to John Decastro, who was diagnosed with lung cancer after years of having maintained his Ford vehicles, whose parts were

Mesothelioma Victims Take Hope from Lung Cancer Immune Therapy Results

One of the first things that a mesothelioma victim is told after their diagnosis is that the disease has a very short life expectancy. Some are told to get their affairs in order, while others may have a prognosis that promises a year, perhaps two. The medical community has been striving to find better treatment

Keytruda (pembrolizumab) for Mesothelioma and Lung Cancer

Keytruda (pembrolizumab) is an immunotherapy drug for cancer treatment approved for patients with specific genetic markers According to ongoing studies, Keytruda may be a useful drug for mesothelioma and asbestos lung cancer. Facts About Keytruda Is Pembrolizumab Approved for Mesothelioma? Unlike other cancer drugs, Keytruda’s FDA approval is based on cancer type but also on

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now